Precigen Good Will vs Total Assets Analysis

PGEN Stock

USD 1.18 0.14 10.61%

Precigen financial indicator trend analysis is much more than just breaking down Precigen prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Precigen is a good investment. Please check the relationship between Precigen Good Will and its Total Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.

Good Will vs Total Assets

Good Will vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Precigen Good Will account and Total Assets. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Precigen's Good Will and Total Assets is 0.95. Overlapping area represents the amount of variation of Good Will that can explain the historical movement of Total Assets in the same time period over historical financial statements of Precigen, assuming nothing else is changed. The correlation between historical values of Precigen's Good Will and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Good Will of Precigen are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Good Will i.e., Precigen's Good Will and Total Assets go up and down completely randomly.

Correlation Coefficient

0.95

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Good Will

An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.

Total Assets

Total assets refers to the total amount of Precigen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Precigen books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most indicators from Precigen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Precigen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.At this time, Precigen's Selling General Administrative is very stable compared to the past year. As of the 9th of January 2025, Discontinued Operations is likely to grow to about 130.5 M, while Tax Provision is likely to drop (553 K).

	2022	2023	2024	2025 (projected)
Interest Expense	6.8M	468K	538.2K	511.3K
Depreciation And Amortization	7.2M	6.7M	7.7M	15.3M

Interest Expense Depreciation And Amortization

Precigen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Inventory
Total Assets		0.1	0.33	0.66	0.85	0.68	0.9	-0.27	0.24	0.71	0.85	0.98	0.18	0.82	0.94	-0.15	0.62	0.18	-0.09	0.04	0.33	0.86	0.89	-0.1	0.93	0.88
Short Long Term Debt Total	0.1		0.68	0.42	-0.05	0.55	-0.19	0.91	-0.53	0.42	0.36	-0.04	-0.89	0.17	0.12	0.21	0.01	0.18	0.38	0.51	0.27	0.2	0.38	0.37	-0.05	0.22
Other Current Liab	0.33	0.68		0.82	0.29	0.52	0.13	0.54	-0.48	0.41	0.42	0.2	-0.58	0.24	0.46	0.38	0.03	-0.05	0.18	0.53	0.14	0.41	0.55	0.62	0.27	0.29
Total Current Liabilities	0.66	0.42	0.82		0.52	0.65	0.55	0.2	-0.18	0.63	0.56	0.58	-0.29	0.41	0.77	0.12	0.22	0.09	0.19	0.31	0.32	0.57	0.72	0.61	0.62	0.5
Total Stockholder Equity	0.85	-0.05	0.29	0.52		0.45	0.72	-0.35	-0.02	0.52	0.66	0.82	0.23	0.83	0.79	0.25	0.72	-0.34	-0.02	0.31	-0.2	0.78	0.81	-0.09	0.78	0.78
Property Plant And Equipment Net	0.68	0.55	0.52	0.65	0.45		0.54	0.29	-0.07	0.9	0.68	0.66	-0.22	0.45	0.64	-0.04	0.19	0.34	-0.06	0.18	0.47	0.67	0.62	0.05	0.62	0.58
Current Deferred Revenue	0.9	-0.19	0.13	0.55	0.72	0.54		-0.48	0.37	0.58	0.62	0.94	0.43	0.62	0.84	-0.21	0.49	0.29	-0.19	-0.18	0.41	0.67	0.66	-0.22	0.94	0.65
Net Debt	-0.27	0.91	0.54	0.2	-0.35	0.29	-0.48		-0.64	0.16	-0.06	-0.39	-0.94	-0.16	-0.23	0.3	-0.18	0.07	0.45	0.5	0.11	-0.12	0.02	0.44	-0.4	-0.11
Retained Earnings	0.24	-0.53	-0.48	-0.18	-0.02	-0.07	0.37	-0.64		0.0	0.17	0.34	0.65	0.07	0.18	-0.89	0.01	0.55	-0.54	-0.91	0.48	0.21	-0.02	-0.39	0.21	0.27
Accounts Payable	0.71	0.42	0.41	0.63	0.52	0.9	0.58	0.16	0.0		0.64	0.68	-0.1	0.56	0.71	-0.05	0.38	0.25	-0.03	0.16	0.39	0.62	0.68	0.06	0.64	0.58
Cash	0.85	0.36	0.42	0.56	0.66	0.68	0.62	-0.06	0.17	0.64		0.78	-0.03	0.78	0.81	-0.19	0.45	0.29	-0.11	0.1	0.41	0.75	0.85	-0.09	0.78	0.79
Non Current Assets Total	0.98	-0.04	0.2	0.58	0.82	0.66	0.94	-0.39	0.34	0.68	0.78		0.32	0.72	0.91	-0.21	0.52	0.23	-0.15	-0.08	0.35	0.81	0.78	-0.19	0.95	0.83
Non Currrent Assets Other	0.18	-0.89	-0.58	-0.29	0.23	-0.22	0.43	-0.94	0.65	-0.1	-0.03	0.32		0.07	0.15	-0.31	0.11	0.01	-0.67	-0.56	-0.06	0.12	-0.13	-0.57	0.32	0.03
Cash And Short Term Investments	0.82	0.17	0.24	0.41	0.83	0.45	0.62	-0.16	0.07	0.56	0.78	0.72	0.07		0.69	0.04	0.9	-0.05	-0.03	0.2	0.05	0.74	0.91	-0.19	0.67	0.8
Net Receivables	0.94	0.12	0.46	0.77	0.79	0.64	0.84	-0.23	0.18	0.71	0.81	0.91	0.15	0.69		-0.1	0.46	0.16	-0.09	0.09	0.33	0.78	0.84	0.09	0.91	0.78
Common Stock Shares Outstanding	-0.15	0.21	0.38	0.12	0.25	-0.04	-0.21	0.3	-0.89	-0.05	-0.19	-0.21	-0.31	0.04	-0.1		0.12	-0.74	0.34	0.86	-0.68	-0.11	0.05	0.21	-0.08	-0.22
Short Term Investments	0.62	0.01	0.03	0.22	0.72	0.19	0.49	-0.18	0.01	0.38	0.45	0.52	0.11	0.9	0.46	0.12		-0.23	0.05	0.22	-0.17	0.57	0.74	-0.19	0.44	0.64
Non Current Liabilities Total	0.18	0.18	-0.05	0.09	-0.34	0.34	0.29	0.07	0.55	0.25	0.29	0.23	0.01	-0.05	0.16	-0.74	-0.23		-0.22	-0.61	0.97	0.05	0.03	-0.2	0.21	0.09
Other Current Assets	-0.09	0.38	0.18	0.19	-0.02	-0.06	-0.19	0.45	-0.54	-0.03	-0.11	-0.15	-0.67	-0.03	-0.09	0.34	0.05	-0.22		0.48	-0.17	-0.34	0.05	0.5	-0.1	-0.1
Other Stockholder Equity	0.04	0.51	0.53	0.31	0.31	0.18	-0.18	0.5	-0.91	0.16	0.1	-0.08	-0.56	0.2	0.09	0.86	0.22	-0.61	0.48		-0.51	0.07	0.3	0.35	0.02	0.03
Total Liab	0.33	0.27	0.14	0.32	-0.2	0.47	0.41	0.11	0.48	0.39	0.41	0.35	-0.06	0.05	0.33	-0.68	-0.17	0.97	-0.17	-0.51		0.18	0.2	-0.05	0.34	0.21
Property Plant And Equipment Gross	0.86	0.2	0.41	0.57	0.78	0.67	0.67	-0.12	0.21	0.62	0.75	0.81	0.12	0.74	0.78	-0.11	0.57	0.05	-0.34	0.07	0.18		0.83	-0.09	0.67	0.93
Total Current Assets	0.89	0.38	0.55	0.72	0.81	0.62	0.66	0.02	-0.02	0.68	0.85	0.78	-0.13	0.91	0.84	0.05	0.74	0.03	0.05	0.3	0.2	0.83		0.11	0.74	0.85
Short Term Debt	-0.1	0.37	0.62	0.61	-0.09	0.05	-0.22	0.44	-0.39	0.06	-0.09	-0.19	-0.57	-0.19	0.09	0.21	-0.19	-0.2	0.5	0.35	-0.05	-0.09	0.11		-0.15	-0.11
Intangible Assets	0.93	-0.05	0.27	0.62	0.78	0.62	0.94	-0.4	0.21	0.64	0.78	0.95	0.32	0.67	0.91	-0.08	0.44	0.21	-0.1	0.02	0.34	0.67	0.74	-0.15		0.66
Inventory	0.88	0.22	0.29	0.5	0.78	0.58	0.65	-0.11	0.27	0.58	0.79	0.83	0.03	0.8	0.78	-0.22	0.64	0.09	-0.1	0.03	0.21	0.93	0.85	-0.11	0.66

Click cells to compare fundamentals

Precigen Account Relationship Matchups

Precigen fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	314.6M	359.9M	216.0M	151.0M	135.9M	129.1M
Short Long Term Debt Total	182.3M	194.2M	51.4M	7.1M	8.2M	7.8M
Other Current Liab	31.7M	28.6M	30.1M	19.5M	22.5M	30.4M
Total Current Liabilities	42.1M	34.6M	78.6M	23.0M	26.4M	25.1M
Total Stockholder Equity	67.2M	107.3M	126.3M	118.5M	136.3M	241.2M
Property Plant And Equipment Net	44.3M	45.2M	15.4M	14.2M	16.3M	15.5M
Current Deferred Revenue	2.8M	4.4M	25K	509K	458.1K	435.2K
Net Debt	130.5M	151.3M	46.6M	(481K)	(553.2K)	(525.5K)
Retained Earnings	(1.8B)	(1.9B)	(1.9B)	(2.0B)	(1.8B)	(1.7B)
Accounts Payable	4.6M	3.1M	4.1M	1.7M	2.0M	1.9M
Cash	51.8M	42.9M	4.9M	7.6M	6.8M	6.5M
Non Current Assets Total	165.6M	203.2M	97.8M	82.3M	74.1M	70.4M
Non Currrent Assets Other	(8.6M)	(14.8M)	(8.5M)	497K	447.3K	469.7K
Cash And Short Term Investments	100.1M	115.2M	56.0M	62.9M	56.6M	93.0M
Net Receivables	20.4M	2.0M	13.8M	1.6M	1.4M	1.3M
Common Stock Shares Outstanding	167.1M	197.8M	200.4M	244.5M	281.2M	295.3M
Short Term Investments	48.3M	72.2M	51.1M	55.3M	49.7M	53.0M
Liabilities And Stockholders Equity	314.6M	359.9M	216.0M	151.0M	135.9M	129.1M
Non Current Liabilities Total	205.3M	217.9M	11.1M	9.6M	8.6M	8.2M
Other Current Assets	17.0M	45.7M	48.1M	4.3M	5.0M	4.7M
Other Stockholder Equity	1.9B	2.0B	2.0B	2.1B	2.4B	1.3B
Total Liab	247.4M	252.5M	89.7M	32.5M	29.3M	27.8M
Property Plant And Equipment Gross	43.4M	34.3M	7.3M	38.4M	34.6M	28.2M
Total Current Assets	148.9M	156.6M	118.2M	68.8M	79.1M	75.1M
Accumulated Other Comprehensive Income	4.0M	203K	(3.5M)	(1.9M)	(2.2M)	(2.4M)
Short Term Debt	3.0M	1.4M	44.4M	1.2M	1.4M	1.3M
Intangible Assets	65.4M	54.1M	44.5M	40.7M	36.6M	34.8M
Inventory	16.1M	11.4M	13.3M	287K	0.9	0.86
Good Will	54.4M	54.1M	36.9M	26.6M	24.0M	22.8M
Net Tangible Assets	(60.4M)	(52.6M)	(915K)	126.3M	113.6M	81.8M
Long Term Debt	211.2M	186.3M	171.5M	182.7M	210.2M	107.7M
Retained Earnings Total Equity	(1.7B)	(1.8B)	(1.9B)	(1.9B)	(1.7B)	(1.8B)
Long Term Debt Total	211.2M	186.3M	171.5M	182.7M	210.2M	107.7M
Capital Surpluse	1.8B	1.9B	2.0B	2.0B	2.3B	1.7B
Deferred Long Term Liab	7.2M	2.8M	2.9M	2.5M	2.3M	2.2M
Non Current Liabilities Other	57.4M	72.0M	30.9M	32.6M	37.5M	27.7M
Property Plant Equipment	61.0M	34.9M	45.2M	7.3M	6.6M	6.3M

Pair Trading with Precigen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Precigen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Precigen will appreciate offsetting losses from the drop in the long position's value.

The ability to find closely correlated positions to Precigen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Precigen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Precigen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Precigen to buy it.

The correlation of Precigen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Precigen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Precigen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Precigen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:

How To Invest In Precigen

Details

Is Precigen Stock a good investment?

Details

What is Precigen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.

You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.54)

Revenue Per Share

0.018

Quarterly Revenue Growth

(0.59)

Return On Assets

(0.42)

Return On Equity

(1.29)

The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Precigen Good Will vs Total Assets Analysis

Good Will vs Total Assets

Good Will vs Total Assets Correlation Analysis

Correlation Coefficient

Good Will

Total Assets

Precigen fundamental ratios Correlations

Precigen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Precigen fundamental ratios Accounts

Pair Trading with Precigen

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 0.98	Total Assets
Total Liab	+ 0.97	Non Current Liabilities Total
Intangible Assets	+ 0.95	Non Current Assets Total
Net Receivables	+ 0.94	Total Assets
Non Current Assets Total	+ 0.94	Current Deferred Revenue
Intangible Assets	+ 0.94	Current Deferred Revenue

Non Currrent Assets Other	- 0.94	Net Debt
Other Stockholder Equity	- 0.91	Retained Earnings
Common Stock Shares Outstanding	- 0.89	Retained Earnings
Non Currrent Assets Other	- 0.89	Short Long Term Debt Total
Non Current Liabilities Total	- 0.74	Common Stock Shares Outstanding
Total Liab	- 0.68	Common Stock Shares Outstanding